Financial Performance - The company reported a revenue of HKD 3,640.2 million for the year 2019, reflecting a compound annual growth rate (CAGR) of 12.6% from 2016 to 2019[14]. - The company's revenue for the year ended December 31 was HKD 3,640.2 million, a decrease of 2.9% compared to HKD 3,749.1 million in the previous year[26]. - Adjusted net profit attributable to shareholders was HKD 538.8 million, up 31.5% from HKD 409.6 million in the previous year[26]. - Basic earnings per share increased by 16.5% to HKD 31.8 cents from HKD 27.3 cents[26]. - EBITDA for the year was HKD 1,082.8 million, representing a 13.7% increase from HKD 952.6 million in the previous year[24]. - Gross profit fell by 6.3% to HKD 1,131.5 million, with a gross margin of 31.1%, down from 32.2% in the previous year[42]. - The company reported a net profit of HKD 539.0 million, representing a 31.0% increase compared to HKD 411.5 million in 2018[38]. - Operating profit increased by 21.3% to HKD 696.5 million, with an operating margin of 19.1%, up from 15.3% in the previous year[38]. - Total revenue for the year was HKD 3,640.2 million, representing a decrease of 2.9% compared to the previous year[32]. - The company experienced a significant reduction in financing costs, which decreased by 33.3% to HKD 58.0 million[38]. Market and Operational Insights - The company is the seventh largest independent investment casting manufacturer globally and the largest in China, with precision machining accounting for 30.7% of its revenue[14]. - The company has over 7,100 employees, including more than 600 engineers from around the world, and serves approximately 1,600 customers across over 30 countries[16]. - The company operates 15 production facilities globally, with sales offices and warehousing capabilities in China, the Americas, Luxembourg, Germany, Turkey, and Hong Kong[18]. - The company aims to provide a one-stop solution, including R&D, mold design and manufacturing, casting, secondary machining, heat treatment, and surface treatment[14]. - The company has established long-term strategic partnerships with several globally recognized industry leaders[13]. - The company is focused on innovation and efficiency, aiming to minimize non-value-added activities and enhance operational effectiveness[10]. Revenue Breakdown - Revenue from the automotive end market decreased by 6.2% year-on-year to HKD 1,637.5 million, accounting for 45.0% of total revenue[31]. - Revenue from the industrial end market declined by 5.2% year-on-year to HKD 1,553.9 million, primarily due to protectionism in global trade[31]. - Revenue from the aerospace and medical end markets grew by 23.0% year-on-year to HKD 448.8 million, driven by strong demand in these sectors[31]. - Revenue from precision machining parts decreased by 7.9% to HKD 1,118.7 million, primarily due to weak demand in the commercial vehicle and hydraulic equipment markets[28]. - Surface treatment revenue fell by 21.7% to HKD 274.8 million, impacted by declining demand in the passenger vehicle market in mainland China[28]. Strategic Initiatives - The company is investing in a new production facility in San Luis Potosí, Mexico, with a total land area of 227,474 square meters, aimed at mitigating supply chain risks[33]. - The company plans to implement a "dual-engine growth" strategy focusing on organic growth and strategic acquisitions to enhance its market position[36]. - The company aims to balance its market coverage across automotive, industrial, aerospace, and medical sectors to improve profitability and growth potential[35]. - The company continues to focus on high-precision and high-complexity products while implementing a "Local For Local" strategy to enhance operational efficiency[33]. Corporate Governance and Management - The company has committed to maintaining high corporate governance standards to enhance shareholder value and transparency[82]. - The board consists of five executive directors and three independent non-executive directors as of December 31, 2019[84]. - The audit committee held two meetings during the year, with all members present at each meeting[93]. - The remuneration committee held one meeting during the year, with all members present[96]. - The company has a formal and transparent nomination policy for selecting and appointing new directors[88]. - The company emphasizes fair and transparent procedures for all shareholders to exercise their rights and engage in effective communication[115]. Shareholder Information - The company maintained a dividend payout ratio of 25% for the fiscal year 2019, with dividends increasing approximately 60% since 2016[74]. - The interim dividend for the fiscal year 2019 was set at HKD 0.04 per share, while the final dividend was HKD 0.032 per share[78]. - As of December 31, 2019, the company's distributable reserves for dividends amounted to HKD 1,636.5 million[139]. - The company has a public float exceeding 25% of its issued shares as of the report date[174]. Audit and Compliance - The independent auditor for the group is KPMG, with total fees paid/owed amounting to HKD 7.4 million for the year ended December 31, 2019, down from HKD 11.1 million in 2018[110]. - The audit committee has confirmed that the group has maintained an appropriate, effective, and adequate internal control and enterprise risk management system throughout the period from listing to December 31, 2019[114]. - The audit identified the trade receivables loss provision as a key audit matter due to the significant management judgment involved in determining the provision[184]. - The audit identified the assessment of goodwill impairment as a key audit matter due to the inherent complexity and management's subjective judgment involved[188]. Employee and Compensation - The total employee costs for the year reached HKD 965.0 million, up from HKD 948.0 million in 2018, reflecting a year-on-year increase of approximately 1.3%[69]. - The total remuneration for executive directors as of December 31, 2019, amounted to HKD 14,049,000, with performance bonuses contributing HKD 2,323,000[100]. - The five highest-paid individuals in the group received a total remuneration of HKD 15,370,000, including performance bonuses of HKD 2,651,000[103]. - The remuneration for independent non-executive directors was set at HKD 225,000 each, effective from April 1, 2019[101]. Future Outlook - The impact of the COVID-19 pandemic on the company's operations and supply chain remains uncertain, with potential fluctuations in demand across different end markets[36]. - The company is well-positioned for future growth with a diverse and experienced management team, ready to tackle market challenges and opportunities[126][128].

Financial Performance - Revenue increased to HKD 1,911.1 million, a 2.3% increase compared to the same period last year; in local currency, it increased by 6.1%[3] - Gross profit rose to HKD 612.4 million, with a gross margin of 32.0% (up from 31.7% in the same period last year)[3] - EBITDA increased to HKD 588.8 million, with an EBITDA margin of 30.8% (up from 29.6% last year)[3] - Operating profit rose to HKD 394.3 million, with an operating margin of 20.6% (up from 19.7% last year)[3] - Net profit attributable to shareholders increased to HKD 300.2 million, an 11.1% increase compared to HKD 270.1 million in the same period last year[4] - Adjusted net profit attributable to shareholders rose to HKD 328.2 million, a 4.7% increase year-on-year[3] - Earnings per share (basic and diluted) were HKD 0.199, a 10.6% increase compared to the same period last year[3] - The group's revenue for the six months ended June 30, 2019, increased by 2.3% to HKD 1,911.1 million, compared to HKD 1,867.8 million in the same period of 2018[12] - Adjusted net profit attributable to shareholders increased by 11.1% to HKD 300.2 million, compared to HKD 270.1 million in the same period of 2018[17] - The net profit attributable to equity holders for the six months ended June 30, 2019, was HKD 300.2 million, up 11.1% from HKD 270.1 million in the same period of 2018, resulting in a net profit margin increase from 14.5% to 15.7%[35] Revenue Segmentation - The investment in the precision machining segment generated revenue of HKD 624.3 million, a 1.2% increase year-on-year[5] - Revenue from the aerospace and medical end markets increased by 33.2%, accounting for 11.3% of total revenue[8] - Revenue from the Americas rose significantly, with sales reaching HKD 835.0 million, accounting for 43.7% of total revenue, up from 39.7% in 2018[12] - Revenue for the six months ended June 30, 2019, was HKD 1,911,085 thousand, an increase of 2.6% compared to HKD 1,867,804 thousand in 2018[57] - Revenue from external customers for the first half of 2019 was HKD 1,911,085,000, a 2.6% increase from HKD 1,867,804,000 in the same period of 2018[102] Cost and Expenses - Selling and distribution expenses increased by 21.2% to HKD 82.0 million, primarily due to additional U.S. tariffs amounting to HKD 10.7 million[24] - Administrative and other operating expenses decreased by 13.0% to HKD 151.9 million, excluding listing expenses[25] - Net financing costs rose to HKD 45.3 million from HKD 43.5 million, attributed to higher LIBOR and HIBOR rates[26] - The total employee cost for the six months ended June 30, 2019, was HKD 473.5 million, compared to HKD 464.3 million for the same period in 2018, reflecting an increase of approximately 2.6%[50] Cash Flow and Liquidity - Cash and cash equivalents increased significantly by 451.1% to HKD 1,309.9 million as of June 30, 2019, compared to HKD 237.7 million at the end of 2018[17] - Cash flow from operating activities was HKD 481.0 million, an increase of 14.4% from HKD 420.5 million in the previous year[38] - Cash used in investing activities was HKD 300.9 million, up from HKD 286.5 million in the same period last year, mainly for capital expenditures[38] - Cash flow from financing activities was HKD 892.1 million, a significant increase from a cash outflow of HKD 141.7 million in the previous year, primarily due to net proceeds from the global offering[40] Assets and Liabilities - Total assets increased by 21.6% to HKD 6,770.1 million as of June 30, 2019, while total equity rose by 41.4% to HKD 3,796.3 million compared to December 31, 2018[36] - The current ratio improved to 1.49 as of June 30, 2019, from 1.06 as of December 31, 2018, primarily due to increased bank balances from global offering proceeds[36] - Total inventory increased by HKD 65.9 million to HKD 804.3 million, mainly due to restored inventory levels in the U.S. and increased production to meet strong customer demand[29] - Trade receivables decreased by HKD 48.7 million to HKD 870.8 million, reflecting the company's efforts to collect outstanding trade debts[31] Dividend and Shareholder Information - The interim dividend declared is HKD 0.04 per share, reflecting the company's profitability and need for financial resources for business expansion[16] - The company declared an interim dividend of HKD 0.04 per share for the six months ended June 30, 2019, totaling approximately HKD 75.3 million, compared to zero for the same period in 2018[145] - Major shareholder Impro Development holds 1,137,790,787 shares, representing 62.06% of the company's issued share capital[154] - Baring Private Equity Asia V Holding owns 237,153,654 shares, accounting for 12.94% of the total issued shares[154] Corporate Governance and Compliance - The company has adopted the Corporate Governance Code and has complied with all provisions during the reporting period, except for the separation of the roles of Chairman and CEO[147] - The company has established an audit committee, nomination committee, and remuneration committee to ensure compliance with corporate governance standards[148] - The audit committee has reviewed the unaudited interim results for the six months ending June 30, 2019, in accordance with international auditing standards[166] IFRS 16 Adoption - The company has adopted the new International Financial Reporting Standard 16 (IFRS 16) for leases, which requires capitalization of all leases except for short-term leases and low-value assets[75] - The initial application of IFRS 16 resulted in adjustments to the equity balance as of January 1, 2019, but comparative figures have not been restated[76] - The group recognized lease liabilities totaling HKD 158,836,000 as of January 1, 2019, following the adoption of IFRS 16, with a present value of remaining lease payments discounted using a weighted average incremental borrowing rate of 4.60%[79] Share Options and Employee Incentives - The company granted 30,230,000 share options to directors and employees at an exercise price of HKD 2.40, which is a 20% discount to the IPO price[132] - The stock options are designed to incentivize employees and align their interests with the company's performance[159] - The maximum number of shares that can be issued upon the exercise of options granted under the post-IPO share option plan is capped at 10% of the issued shares as of the listing date, totaling 183,330,000 shares[163]